227 related articles for article (PubMed ID: 26392442)
1. Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrest.
Walton G; Nolan S; Sutherland C; Ahamad K
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392442
[TBL] [Abstract][Full Text] [Related]
2. Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Baschirotto C; Lehmann K; Kuhn S; Reimer J; Verthein U
J Pharmacol Sci; 2020 Sep; 144(1):9-15. PubMed ID: 32586692
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of slow-release oral morphine versus methadone in the treatment of opioid dependence.
Hämmig R; Köhler W; Bonorden-Kleij K; Weber B; Lebentrau K; Berthel T; Babic-Hohnjec L; Vollmert C; Höpner D; Gholami N; Verthein U; Haasen C; Reimer J; Ruckes C
J Subst Abuse Treat; 2014 Oct; 47(4):275-81. PubMed ID: 25064422
[TBL] [Abstract][Full Text] [Related]
4. Slow-release oral morphine as maintenance therapy for opioid dependence.
Ferri M; Minozzi S; Bo A; Amato L
Cochrane Database Syst Rev; 2013 Jun; (6):CD009879. PubMed ID: 23740540
[TBL] [Abstract][Full Text] [Related]
5. Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes.
Esses JL; Rosman J; Do LT; Schweitzer P; Hanon S
J Interv Card Electrophysiol; 2008 Nov; 23(2):117-9. PubMed ID: 18686025
[TBL] [Abstract][Full Text] [Related]
6. Treatment of methadone-induced torsades de pointes with lidocaine.
Rajpal S; Mundi AS; Reddy PC; Akkus NI
J La State Med Soc; 2013; 165(6):338-41. PubMed ID: 25073261
[TBL] [Abstract][Full Text] [Related]
7. Torsades de pointes with methadone.
Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
[TBL] [Abstract][Full Text] [Related]
8. Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.
Socias ME; Wood E; Dong H; Brar R; Bach P; Murphy SM; Fairbairn N
Contemp Clin Trials; 2020 Apr; 91():105993. PubMed ID: 32194251
[TBL] [Abstract][Full Text] [Related]
9. Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.
Beck T; Haasen C; Verthein U; Walcher S; Schuler C; Backmund M; Ruckes C; Reimer J
Addiction; 2014 Apr; 109(4):617-26. PubMed ID: 24304412
[TBL] [Abstract][Full Text] [Related]
10. Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
Kao DP; Haigney MC; Mehler PS; Krantz MJ
Addiction; 2015 Sep; 110(9):1468-75. PubMed ID: 26075588
[TBL] [Abstract][Full Text] [Related]
11. Methadone induced Torsades de Pointes mimicking seizures in clinical presentation.
Raina S; Paydak H; Al-Lahham T; Shihabuddin BS
Am J Drug Alcohol Abuse; 2014 Nov; 40(6):490-2. PubMed ID: 25321151
[No Abstract] [Full Text] [Related]
12. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
[TBL] [Abstract][Full Text] [Related]
13. QTc prolongation and torsades de pointes associated with methadone therapy.
Routhier DD; Katz KD; Brooks DE
J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and quality of life of opioid-dependent pregnant women in Austria.
Metz VE; Comer SD; Wuerzl J; Pribasnig A; Fischer G
Arch Womens Ment Health; 2014 Dec; 17(6):529-39. PubMed ID: 25023716
[TBL] [Abstract][Full Text] [Related]
15. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
[TBL] [Abstract][Full Text] [Related]
16. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
Isbister GK; Brown AL; Gill A; Scott AJ; Calver L; Dunlop AJ
Br J Clin Pharmacol; 2017 Oct; 83(10):2274-2282. PubMed ID: 28488266
[TBL] [Abstract][Full Text] [Related]
17. Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study.
Verthein U; Beck T; Haasen C; Reimer J
Eur Addict Res; 2015; 21(2):97-104. PubMed ID: 25427944
[TBL] [Abstract][Full Text] [Related]
18. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
Kastelic A; Dubajic G; Strbad E
Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
[TBL] [Abstract][Full Text] [Related]
19. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
Bond AJ; Reed KD; Beavan P; Strang J
Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
[TBL] [Abstract][Full Text] [Related]
20. Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation.
Brogdon H; Facer KL; Cox EJ; Carlson RH; Wurzel JF
J Addict Med; 2022 Jul-Aug 01; 16(4):488-491. PubMed ID: 34864786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]